NCT00470327RecruitingAccepts Healthy Volunteers

A Study of the Natural Progression of Interstitial Lung Disease (ILD)

University of Chicago

Start Date

9/1/2005

Completion Date

12/1/2030

Summary

We propose to acquire data and blood samples on all patients being cared for by the Interstitial Lung Disease (ILD) program. Additionally, we will collect data and blood samples from a control group for comparator purposes. In doing so, we will be able to describe the "phenotypic" expression of these diseases.

Eligibility Criteria

Age Range: 18 years to No maximum

Inclusion Criteria: * Interstitial lung disease Exclusion Criteria: * Does not have Interstitial lung disease

Interested in This Trial?

Contact the trial locations directly using the information below to learn more about enrollment.

Expressing interest lets you review the study and consent before we connect you with the research site.

Conditions

Interstitial Lung DiseasesIdiopathic Pulmonary FibrosisSarcoidosisConnective Tissue Disorder

Locations

University of Chicago

Chicago, Illinois 60637

United States

Run studies, or work at a research site?

Corterve helps sites and sponsors reach patients who are looking for trials. It does not determine eligibility and does not promise an enrolment outcome.

For sponsors, CROs and sites

What Corterve sells to organisations, and the anti-kickback constraints it works within.

Services and published prices

Lay summaries for EU CTR Annex V, pre-screen filtration, recruitment-creative regulatory operations, feasibility reporting.

For research sites

One published licence rate, the same for every site, and the fees a site is never charged.